TIL Q2 2021 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$60M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$35M

Net Income

-$35M

EPS (Diluted)

$-0.27

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$41M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$673M

Total Liabilities

$37M

Stockholders' Equity

$635M

Cash & Equivalents

$567M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$42,000	-100.0%
Gross Profit	$0	$42,000	-100.0%
Operating Income	-$35M	-$5M	-670.3%
Net Income	-$35M	-$9M	-283.7%